[1] |
中华医学会神经病学分会帕金森病及运动障碍学组. 中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271.
|
[2] |
Pajares M, Rojo AI, Manda G, et al. Inflammation in Parkinson's disease: Mechanisms and therapeutic implications[J]. Cells, 2020, 9(7):1687.
|
[3] |
Marogianni C, Sokratous M, Dardiotis E, et al. Neurodegeneration and inflammation-An interesting interplay in Parkinson's disease[J]. Int J Mol Sci, 2020, 21(22):8421.
|
[4] |
Sheinenzon A, Shehadeh M, Michelis R, et al. Serum albumin levels and inflammation[J]. Int J Biol Macromol, 2021, 184:857-862.
|
[5] |
Kaplan M, Ates I, Akpinar MY, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(4):424-430.
|
[6] |
Güneş H, Yurttutan S, Çobanuşağı M, et al. CRP/albumin ratio: A promising marker of gram-negative bacteremia in late-onset neonatal sepsis[J]. Turk Arch Pediatr, 2021, 56(1):32-36.
|
[7] |
Chen YH, Wang L, Feng SY, et al. The relationship between C-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease[J]. Gastroenterol Res Pract, 2020, 2020:3467419.
|
[8] |
Yildirim T, Kiris T, Avci E, et al. Increased serum CRP-albumin ratio is independently associated with severity of carotid artery stenosis[J]. Angiology, 2020, 71(8):740-746.
|
[9] |
Faria SS, Fernandes PC Jr, Silva MJ, et al. The neutrophil-to-lymphocyte ratio: A narrative review[J]. Ecancermedicalscience, 2016, 10:702.
|
[10] |
孙雪婷,李可为,余刚.帕金森病免疫炎症机制的研究进展[J].中华神经科杂志,2019,52(8):670-673.
|
[11] |
Baran A, Bulut M, Kaya MC, et al. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease[J]. Neurol Sci, 2019, 40(1):167-173.
|
[12] |
Akıl E, Bulut A, Kaplan İ, et al. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease[J]. Neurol Sci, 2015, 36(3):423-428.
|
[13] |
Memar MY, Alizadeh N, Varshochi M, et al. Immunologic biomarkers for diagnostic of early-onset neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2019, 32(1):143-153.
|
[14] |
Pathak A, Agrawal A. Evolution of C-reactive protein[J]. Front Immunol, 2019, 10:943.
|
[15] |
Qiu X, Xiao Y, Wu J, et al. C-reactive protein and risk of Parkinson's disease: A systematic review and meta-analysis[J]. Front Neurol, 2019,10:384.
|
[16] |
Andican G, Konukoglu D, Bozluolcay M, et al. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease[J]. Acta Neurol Belg, 2012, 112(2):155-159.
|
[17] |
Sawada H, Oeda T, Umemura A, et al. Baseline C-reactive protein levels and life prognosis in Parkinson's disease[J]. PLoS One, 2015, 10(7):e0134118.
|
[18] |
Jin H, Gu HY, Mao CJ, et al. Association of inflammatory factors and aging in Parkinson's disease[J]. Neurosci Lett, 2020, 736:135259.
|
[19] |
Wang L, Hu W, Wang J, et al. Impact of serum uric acid, albumin and their interaction on Parkinson's disease[J]. Neurol Sci, 2017,38(2):331-336.
|
[20] |
Kakinen A, Javed I, Faridi A, et al. Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein[J]. Biochim Biophys Acta Biomembr, 2018, 1860(9):1803-1809.
|
[21] |
Dong X, Nao J, Shi J, et al. Predictive value of routine peripheral blood biomarkers in Alzheimer's disease[J]. Front Aging Neurosci, 2019, 11:332.
|
[22] |
Zenaro E, Pietronigro E, Della Bianca V, et al. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin[J]. Nat Med, 2015, 21(8):880-886.
|
[23] |
Choi SJ, Hong YH, Kim SM, et al. High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis[J]. Sci Rep, 2020, 10(1):428.
|
[24] |
Ohtani R, Nirengi S, Nakamura M, al. High-density lipoprotein subclasses and mild cognitive impairment: Study of outcome and a Polipoproteins in Dementia (STOP-Dementia)1[J]. J Alzheimers Dis, 2018, 66(1):289-296.
|
[25] |
Halazun HJ, Mergeche JL, Mallon KA, et al. Neutrophil-lymphocyte ratio as a predictor of cognitive dysfunction in carotid endarterectomy patients[J]. J Vasc Surg, 2014, 59(3):768-773.
|
[26] |
Kara SP, Altunan B, Unal A. Investigation of the peripheral inflammation (neutrophil-lymphocyte ratio) in two neurodegenerative diseases of the central nervous system[J]. Neurol Sci, 2021, 31:1-9.
|
[27] |
Sharma D, Spring KJ, Bhaskar SMM. Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis[J]. Acta Neurol Scand, 2021, 144(5):486-499.
|
[28] |
Petrone AB, Eisenman RD, Steele KN, et al. Temporal dynamics of peripheral neutrophil and lymphocytes following acute ischemic stroke[J]. Neurol Sci, 2019, 40(9):1877-1885.
|